BA
CORT icon

BlackRock Advisors’s Corcept Therapeutics CORT Stock Holding History

BlackRock Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.85M Buy
254,885
+198,098
+349% +$1.55M ﹤0.01% 1550
2016
Q3 		$369K Buy
56,787
+19,652
+53% +$114K ﹤0.01% 2333
2016
Q2 		$203K Buy
37,135
+4,637
+14% +$24.1K ﹤0.01% 2601
2016
Q1 		$152K Buy
32,498
+2,250
+7% +$8.77K ﹤0.01% 2693
2015
Q4 		$151K Sell
30,248
-11,794
-28% -$53.2K ﹤0.01% 2721
2015
Q3 		$158K Sell
42,042
-1,168
-3% -$5.93K ﹤0.01% 2850
2015
Q2 		$260K Buy
43,210
+5,003
+13% +$30.7K ﹤0.01% 2642
2015
Q1 		$214K Buy
38,207
+2,021
+6% +$7.32K ﹤0.01% 2635
2014
Q4 		$109K Sell
36,186
-1,690
-4% -$5.15K ﹤0.01% 2996
2014
Q3 		$102K Sell
37,876
-3,295
-8% -$8.72K ﹤0.01% 2989
2014
Q2 		$115K Sell
41,171
-3,592
-8% -$10.6K ﹤0.01% 2979
2014
Q1 		$195K Buy
44,763
+2,745
+7% +$9.59K ﹤0.01% 2650
2013
Q4 		$135K Buy
42,018
+2,670
+7% +$5.4K ﹤0.01% 2892
2013
Q3 		$63K Buy
39,348
+2,614
+7% +$4.61K ﹤0.01% 3127
2013
Q2 		$64K Buy
+36,734
New +$66K ﹤0.01% 3102

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors's CORT Position: Q4 2016 in Review

BlackRock Advisors increased its Corcept Therapeutics (CORT) stake by 349% in Q4 2016, buying an estimated $1.55M and bringing the position to 254,885 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1550.

BlackRock Advisors first reported a position in CORT in Q2 2013 and has held it in 15 quarters since. 135 funds tracked by Wall St. Rank hold CORT as of Q4 2016.

  • BlackRock Advisors held 254,885 shares of Corcept Therapeutics worth $1.85M as of Q4 2016.
  • BlackRock Advisors bought 198,098 Corcept Therapeutics shares in Q4 2016, an estimated $1.55M.
  • Corcept Therapeutics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1550 holding.
  • BlackRock Advisors first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • 135 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.